EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC

Huai-Cheng Huang, Yen-Lin Huang, Yi-Ju Chen, Hsin-Yi Wu, Chia-Lang Hsu, Hsiang-Fong Kao, Bin-Chi Liao, Min-Shu Hsieh, Neng-Yu Lin, Yu-Hao Liao, Hsin-Lin Chen, Chun-Nan Chen und 6 weitere

Oncogenesis · 02.10.2024 · 13 (1)

DOI: 10.1038/s41389-024-00532-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncogenesis, online erschienen am 02.10.2024. Verfasst von Huai-Cheng Huang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has revolutionized cancer treatment, but the lack of a reliable predictive biomarker for treatment response remains a challenge. Alpha-1,6-Mannosylglycoprotein 6-β-N-Acetylglucosaminyltransferase 5 (MGAT5) is a key regulator of complex N-glycan synthesis, and its dysregulation is associated with cancer progression. The lectin Phaseolus vulgaris leukoagglutinin (PHA-L) specifically binds to mature MGAT5 products. Previous studies have indicated elevated PHA-L staining in head and neck squamous cell carcinoma (HNSCC), which implies increased activity of MGAT5. However, the specific role of MGAT5 in HNSCC remains unclear. In this study, we found significantly higher PHA-L staining and MGAT5 expression in HNSCC tumors compared to adjacent non-tumor tissues. Using a mass spectrometry (MS)-based glycoproteomic approach, we identified 163 potential protein substrates of MGAT5. Functional analysis revealed that protein substrates of MGAT5 regulated pathways related to T cell proliferation and activation. We further discovered that PD-L1 was among the protein substrates of MGAT5, and the expression of MGAT5 protected tumor cells from cytotoxic T lymphocyte (CTL) killing. Treatment of nivolumab alleviated the protective effects of MGAT5 on CTL activity. Consistently, patients with MGAT5-positive tumors showed improved responses to immunotherapy compared to those with MGAT5-negative tumors. Using purified PD-L1 from HNSCC cells and a glycoproteomic approach, we further deciphered that the N35 and N200 sites carry the majority of complex N-glycans on PD-L1. Our findings highlight the critical role of MGAT5-mediated branched N-glycans on PD-L1 in modulating the interaction with the immune checkpoint receptor PD-1. Consequently, we propose that MGAT5 could serve as a biomarker to predict patients' responses to anti-PD-1 therapy. Furthermore, targeting the branched N-glycans at N35 and N200 of PD-L1 may lead to the development of novel diagnostic and therapeutic approaches.

Autor:innen und Institutionen

  • Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Pathology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Institute of Chemistry, Academia Sinica, Taipei, Taiwan.
  • Instrumentation Center, National Taiwan University, Taipei, Taiwan.
  • Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.

Zitieren

APA

Huang, H. C., Huang, Y. L., Chen, Y. J., Wu, H. Y., Hsu, C. L., Kao, H. F., Liao, B. C., Hsieh, M. S., Lin, N. Y., Liao, Y. H., Chen, H. L., Chen, C. N., Chen, T. C., Wang, C. P., Yang, T. L., Huang, M. C., Lin, M. C., & Lou, P. J. (2024). The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC. Oncogenesis, 13(1). https://doi.org/10.1038/s41389-024-00532-3

Vancouver

Huang HC, Huang YL, Chen YJ, Wu HY, Hsu CL, Kao HF, et al. The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC. Oncogenesis. 2024;13(1). doi:10.1038/s41389-024-00532-3

BibTeX
@article{Huang2024,
  author = {Huang, Huai-Cheng and Huang, Yen-Lin and Chen, Yi-Ju and Wu, Hsin-Yi and Hsu, Chia-Lang and Kao, Hsiang-Fong and Liao, Bin-Chi and Hsieh, Min-Shu and Lin, Neng-Yu and Liao, Yu-Hao and Chen, Hsin-Lin and Chen, Chun-Nan and Chen, Tseng-Cheng and Wang, Cheng-Ping and Yang, Tsung-Lin and Huang, Min-Chuan and Lin, Mei-Chun and Lou, Pei-Jen},
  title = {The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC},
  journal = {Oncogenesis},
  year = {2024},
  volume = {13},
  number = {1},
  doi = {10.1038/s41389-024-00532-3}
}
Kostenlos starten →